Share story
AI Science

QUANTRO receives Austrian grant to develop AI drug discovery platform

QUANTRO receives Austrian grant to develop AI drug discovery platform Image: Primary
QUANTRO Therapeutics said it received a 12-month, non-dilutive research grant from Austria's Research Promotion Agency to develop ASCEND, an AI platform for discovering drugs that target transcription factors, proteins that regulate gene expression. The platform will combine the company's data on gene activity over time with molecular modelling and internal AI tools to identify and improve drug candidates. QUANTRO plans to operate ASCEND primarily on local physical infrastructure in Vienna, reducing reliance on providers outside Europe. Its initial application is oncology; expansion into other disease areas depends on generating or acquiring relevant biological data.
Sources
The Manila Times
Published by Tech & Business, a media brand covering technology and business. This story was sourced from The Manila Times and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Infrastructure
Infrastructure

Pure Data Centres raises $780 million for regional build-out

Pure Data Centres Group, backed by Oaktree Capital Management, has raised $780 million in financing to help fund a build-out across Europe and the Middle East. The financing includes an option to expand it by a further $1.1 billion.

Bloomberg Technology
Security Capital
Security Capital

Sentra raises $150 million to expand security for AI access to corporate data

Sentra announced a $150 million Series C round led by Capital One Ventures to expand technology that protects sensitive corporate information from unauthorized access by AI agents. The financing brings its total funding to more than $250 million, ynetnews reported.

ynetnews
Science
Science

MIT-led team receives up to $38 million for disease-monitoring patch

An MIT-led team has received funding from the U.S. Advanced Research Projects Agency for Health for a four-year project worth up to $38 million to develop a wearable patch that continuously monitors biomarkers of heart disease and sepsis.

MIT News
Capital
Capital

EloElo raises $80M Series C at $500M valuation

India-based EloElo raised an $80M Series C led by Hornbill Capital and NBCU at a $500M valuation, TechCrunch reported. Its Story TV microdrama app has 33M+ estimated active users. The financing comes as more than 118 million users watch microdramas every month in India.

Techmeme